Domestic Pharmaceutical Firms Set Aggressive Growth Plans for Next Year

Published: 2004-12-14 06:54:00

Updated: 2004-12-14 06:54:00

As the domestic pharmaceutical industry is receiving a number of positive market expectations for the upcoming year, driven by such factors as continued market share increase by ethical generics, potential launchings of new drugs, and National Health Insurance (NHI) financial surplus, the majorit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK